A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies

Several different Physician Global Assessment (PGA) versions have been used in clinical studies as a co-primary end point to evaluate psoriasis severity. Tofacitinib is an oral Janus kinase inhibitor. We perfo...

Source: BMC Dermatology - June 7, 2019 Category: Dermatology Authors: Kristina Callis Duffin, Andrew G. Bushmakin, Joseph C. Cappelleri, Lotus Mallbris and Carla Mamolo Tags: Research article Source Type: research